2/24
07:16 am
fulc
Form S-8 Fulcrum Therapeutics,
Medium
Report
Form S-8 Fulcrum Therapeutics,
2/24
07:11 am
fulc
Form 10-K Fulcrum Therapeutics, For: Dec 31
High
Report
Form 10-K Fulcrum Therapeutics, For: Dec 31
2/24
07:05 am
fulc
Form 8-K Fulcrum Therapeutics, For: Feb 24
Medium
Report
Form 8-K Fulcrum Therapeutics, For: Feb 24
2/17
04:30 pm
fulc
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
Low
Report
Form SCHEDULE 13G/A Fulcrum Therapeutics, Filed by: RA CAPITAL MANAGEMENT, L.P.
2/4
04:15 pm
fulc
Form 4/A Fulcrum Therapeutics, For: Jan 02 Filed by: Gould Robert J
Medium
Report
Form 4/A Fulcrum Therapeutics, For: Jan 02 Filed by: Gould Robert J
2/4
04:10 pm
fulc
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Oltmans Curtis Gale
Medium
Report
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Oltmans Curtis Gale
2/4
04:10 pm
fulc
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Musso Alan A
Medium
Report
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Musso Alan A
2/4
04:10 pm
fulc
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Gould Robert J
Medium
Report
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Gould Robert J
2/4
04:10 pm
fulc
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Tourangeau Greg
Medium
Report
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Tourangeau Greg
2/4
04:10 pm
fulc
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Sapir Alex
Medium
Report
Form 4 Fulcrum Therapeutics, For: Feb 02 Filed by: Sapir Alex
1/12
08:19 am
fulc
Form 8-K Fulcrum Therapeutics, For: Jan 12
Medium
Report
Form 8-K Fulcrum Therapeutics, For: Jan 12
1/6
04:30 pm
fulc
Form 4 Fulcrum Therapeutics, For: Jan 02 Filed by: Gould Robert J
Low
Report
Form 4 Fulcrum Therapeutics, For: Jan 02 Filed by: Gould Robert J
12/17
04:10 pm
fulc
Form 4 Fulcrum Therapeutics, For: Dec 15 Filed by: Oltmans Curtis Gale
Low
Report
Form 4 Fulcrum Therapeutics, For: Dec 15 Filed by: Oltmans Curtis Gale
12/15
04:33 pm
fulc
Form 144 Fulcrum Therapeutics, Filed by: Oltmans Curtis Gale
Medium
Report
Form 144 Fulcrum Therapeutics, Filed by: Oltmans Curtis Gale